Literature DB >> 21435075

Health-related quality of life in paediatric patients with inflammatory bowel disease related to disease activity.

Johanna Haapamäki1, Risto P Roine, Harri Sintonen, Kaija-Leena Kolho.   

Abstract

AIM: Impaired health-related quality of life (HRQoL) and an increased risk of psychosocial problems may encounter children and adolescents with inflammatory bowel disease (IBD). Generic HRQoL questionnaires, 15D designed for subjects over 16 years of age, 16D for adolescents aged 12-15 and 17D for younger children, allow comparison to healthy peers and have not been used in children with IBD before. Further, in paediatric IBD patients, HRQoL has not been related to disease activity. We evaluated the applicability of 15D, 16D and 17D questionnaires in the paediatric IBD population and examined how HRQoL is influenced by changes in clinical activity of IBD.
METHODS: The study subjects recruited at their scheduled, routine appointment in the outpatient clinic of the children's hospital completed the HRQoL questionnaire at baseline and again after 3-5 months. Disease activity was estimated by a three-level scale. The HRQoL of the study population was compared with that of the age-standardised general population.
RESULTS: Fifty-five children, aged 7-19 years, were recruited. The HRQoL scores strongly correlated with the activity of the disease (P < 0.001). The two oldest age groups with IBD had lower HRQoL scores than age-standardised peers (P= 0.001/0.04). There was no gender difference in HRQoL scores.
CONCLUSIONS: IBD has a considerable impact on the HRQoL of children and adolescents. The generic HRQoL instruments used appeared to be promising tools for examining HRQoL in paediatric IBD patients in different age groups, but larger studies to establish their usefulness in the follow-up of young patients are still warranted.
© 2011 The Authors. Journal of Paediatrics and Child Health © 2011 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Year:  2011        PMID: 21435075     DOI: 10.1111/j.1440-1754.2011.02034.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  16 in total

1.  Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels.

Authors:  Anssi Hämäläinen; Taina Sipponen; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

2.  C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease.

Authors:  E Nissilä; K Korpela; A I Lokki; R Paakkanen; S Jokiranta; W M de Vos; M-L Lokki; K-L Kolho; S Meri
Journal:  Clin Exp Immunol       Date:  2017-09-25       Impact factor: 4.330

3.  The health-related quality-of-life impact of nocturnal awakenings in the middle-aged and older Finnish population.

Authors:  Saku Väätäinen; Henri Tuomilehto; Jouko Saramies; Jaakko Tuomilehto; Hannu Uusitalo; Esko Hussi; Sirkka Keinänen-Kiukaanniemi; Janne Martikainen
Journal:  Qual Life Res       Date:  2013-04-03       Impact factor: 4.147

4.  Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.

Authors:  Kaija-Leena Kolho; Taina Sipponen; Elsa Valtonen; Erkki Savilahti
Journal:  Int J Colorectal Dis       Date:  2014-01       Impact factor: 2.571

5.  Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.

Authors:  Kaija-Leena Kolho; Katri Korpela; Tytti Jaakkola; Madharasi V A Pichai; Erwin G Zoetendal; Anne Salonen; Willem M de Vos
Journal:  Am J Gastroenterol       Date:  2015-05-19       Impact factor: 10.864

Review 6.  A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations.

Authors:  Gang Chen; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

7.  Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease.

Authors:  Anu E Castaneda; Annamari Tuulio-Henriksson; Eeva T Aronen; Mauri Marttunen; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

Review 8.  Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties.

Authors:  Xin-Lin Chen; Liang-Huan Zhong; Yi Wen; Tian-Wen Liu; Xiao-Ying Li; Zheng-Kun Hou; Yue Hu; Chuan-Wei Mo; Feng-Bin Liu
Journal:  Health Qual Life Outcomes       Date:  2017-09-15       Impact factor: 3.186

9.  Health-related quality of life in Chinese patients with mild and moderately active ulcerative colitis.

Authors:  Kai Zheng; Shengsheng Zhang; Chuijie Wang; Wenxia Zhao; Hong Shen
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

10.  Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis.

Authors:  Pauliina Nousiainen; Laura Merras-Salmio; Kristiina Aalto; Kaija-Leena Kolho
Journal:  BMC Complement Altern Med       Date:  2014-04-04       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.